
ARTL P/E Ratio
P/E Ratio as of Jul 24, 2025: -0.77
Average-1.65
Median-1.03
Minimum-4.43
Maximum-0.7700
-0.77
Past Month+1.17 (60.31%)
The P/E ratio for ARTL is -0.77 as of Jul 24, 2025. This represents a increase of 28.33% compared to its 12-month average P/E ratio of -0.6. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Artelo Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Artelo Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Artelo Biosciences Inc to industry peers.
Artelo Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Artelo Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Artelo Biosciences Inc to industry peers.
ARTL P/E Ratio Insights
See Artelo Biosciences Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ARTL
Order type
Buy in
Order amount
Est. shares
0 shares
ARTL P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $9.50 | -3.17 |
Jun 2, 2025 | $6.60 | -0.37 |
May 1, 2025 | $6.06 | -0.34 |
Apr 1, 2025 | $5.1603 | -0.29 |
Mar 3, 2025 | $6.00 | -0.33 |
Feb 3, 2025 | $7.0812 | -0.39 |
Jan 2, 2025 | $6.54 | -0.36 |
ARTL End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.77 | +120.00% |
2024 | -0.35 | -16.67% |
2023 | -0.42 | -48.78% |
2022 | -0.82 | -99.35% |
2021 | -127.00 | +17,538.89% |
2020 | -0.72 | — |
FAQs About Artelo Biosciences Inc (ARTL) P/E ratio
The latest P/E ratio of ARTL is -0.77, as of Jul 24, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Artelo Biosciences Inc’s last 12-month average P/E ratio is -0.6, compared to its current P/E ratio of -0.77. This reflects a increase of 28.33%.
Artelo Biosciences Inc’s current P/E ratio of -0.77 is higher than its last 12-month average P/E of -0.6. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Artelo Biosciences Inc’s average P/E ratio over the last 3 years is -0.62. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Artelo Biosciences Inc’s average P/E ratio over the last 5 years is -8.9. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.